Cardio Diagnostics Holdings, Inc. (CDIO) vs Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)

A side-by-side comparison of Cardio Diagnostics Holdings, Inc. and Cuprina Holdings (Cayman) Limited Class A Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Cardio Diagnostics Holdings, Inc. logo
CDIO
Cardio Diagnostics Holdings, Inc.
$6M
$2.06HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares logo
CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
$6M
$2.25HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — CDIO vs CUPR

growth of $100 · dividends reinvested · last 1y
CDIO -80.3% (-80.3%/yr)CUPR -93.2% (-93.2%/yr)CDIO compounded faster over this window
050100150200Start $1002026$20$7
CDIO CUPR

CDIO vs CUPR: by the numbers

  • •CDIO is the larger company ($6M vs $6M market cap).
  • •Both run net losses; CUPR's is the smaller (-9366.75% vs -44771.83% net margin).

Metrics side by side

Valuation

MetricCDIOCUPR
P/S ratio421.90N/A
P/B ratio0.821.54

Profitability

MetricCDIOCUPR
Gross margin100.00%-1.29%
Operating margin-43737.46%-9154.62%
Net margin-44771.83%-9366.75%
ROE-87.12%-92.44%
ROIC-82.84%-84.15%

Go deeper

Full CDIO analysisFull CUPR analysisInteractive comparison tool

Dig into the metrics

Cardio Diagnostics ROECuprina Holdings (Cayman) Limited Class A Ordinary Shares ROECardio Diagnostics operating marginCuprina Holdings (Cayman) Limited Class A Ordinary Shares operating marginCardio Diagnostics revenue growthCuprina Holdings (Cayman) Limited Class A Ordinary Shares revenue growthCardio Diagnostics free cash flowCuprina Holdings (Cayman) Limited Class A Ordinary Shares free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.